Variables | Mortality n/Total (%) | Unadjusted OR (95% CI) | P value | Adjusteda OR (95% CI) | P value |
---|---|---|---|---|---|
IDC | |||||
 Yes | 10/91 (11.0) |  |  |  |  |
 No | 21/37 (56.8) | 10.63(4.20–26.89) | < 0.001 | 7.84 (2.95–20.86) | < 0.001 |
Age (years) | |||||
 < 65 | 10/53 (18.9) |  |  |  |  |
 ≥ 65 | 21/75 (28.0) | 1.67 (0.71–3.94) | 0.239 | 0.69 (0.19–2.44) | 0.562 |
Age (years) | |||||
 < 75 | 15/86 (17.4) |  |  |  |  |
 ≥ 75 | 16/42 (38.1) | 2.91 (1.26–6.74) | 0.012 | 1.56 (0.50–4.87) | 0.441 |
Gender | |||||
 Female | 13/59 (22.0) |  |  |  |  |
 Male | 18/69 (26.1) | 1.25 (0.55–2.84) | 0.595 | 1.54 (0.56–4.28) | 0.407 |
Charlson comorbidity index | |||||
 Score < 5 | 5/50 (10.0) |  |  |  |  |
 Score ≥ 5 | 26/78 (33.3) | 4.50 (1.59–12.75) | 0.005 | 5.14 (1.22–21.58) | 0.025 |
Appropriate antibiotic therapy | |||||
 Yes | 17/88 (19.3) |  |  |  |  |
 No | 14/40 (35.0) | 0.44 (0.19–1.03) | 0.059 | 0.38 (0.06–2.26) | 0.289 |
Surgical intervention for source control | 2/21 (9.5) | Â | Â | Â | Â |
29/107 (27.1) | 3.53 (0.77–16.22) | 0.105 | 2.64 (0.44–15.77) | 0.287 | |
Febrile neutropenia | |||||
 No | 22/83 (26.5) |  |  |  |  |
 Yes | 9/45 (20.0) | 0.69 (0.29–1.67) | 0.415 | 0.97 (0.33–2.89) | 0.963 |
Immunocompromised | |||||
 No | 11/45 (24.4) |  |  |  |  |
 Yes | 20/83 (24.1) | 0.98 (0.42–2.29) | 0.965 | 0.64 (0.19–2.14) | 0.474 |
Haemodynamic status at presentation | |||||
 No shock | 2/63 (3.2) |  |  |  |  |
 In shock | 29/65 (44.6) | 24.57 (5.50–109.76) | < 0.001 | 45.77 (10.30–203.41) | < 0.001 |
Source of bacteraemia b | |||||
 Pulmonary | 11/20 (55.0) | 5.38 (1.96–14.76) | 0.001 | 3.32 (0.96–11.46) | 0.058 |
 Invasive intravascular catheters | 2/32 (6.3) | 0.15 (0.03–0.69) | 0.015 | 0.18 (0.04–0.90) | 0.036 |
 Urinary tract | 1/18 (5.6) | 0.16 (0.02–1.24) | 0.079 | 0.17 (0.02–1.32) | 0.091 |
 Skin & soft tissue | 2/13 (15.4) | 0.54 (0.11–2.59) | 0.441 | 0.88 (0.11–6.99) | 0.907 |
 Unknown | 14/41 (34.2) | 2.14 (0.92–4.94) | 0.076 | 1.73 (0.67–4.44) | 0.256 |